Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tore Stokland"'
Autor:
Kjeld Schmiegelow, Christoffer Johansen, Astrid Sehested, Lisa Hjalgrim, Göran Gustafson, Tore Stokland, Catarina Träger, Päivi Lähteenmäki, Joachim Schüz, Lisbeth Samsø Schmidt
Background: The peak incidence of central nervous system (CNS) tumors in childhood indicates that intrauterine or neonatal characteristics are potential risk factors or symptoms of early onset of disease.Methods: We conducted a registry-based case-co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0d15c12bfad4dec1044a1fa8fad9797
https://doi.org/10.1158/1055-9965.c.6515190
https://doi.org/10.1158/1055-9965.c.6515190
Autor:
Kjeld Schmiegelow, Christoffer Johansen, Astrid Sehested, Lisa Hjalgrim, Göran Gustafson, Tore Stokland, Catarina Träger, Päivi Lähteenmäki, Joachim Schüz, Lisbeth Samsø Schmidt
Supplementary Appendix from Fetal Growth, Preterm Birth, Neonatal Stress and Risk for CNS Tumors in Children: A Nordic Population- and Register-Based Case-Control Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::574091221cfef53bdd32346bba833c3f
https://doi.org/10.1158/1055-9965.22435983.v1
https://doi.org/10.1158/1055-9965.22435983.v1
Autor:
Astrid Gnekow, A. Y. N. Schouten-van Meeteren, Thomas Czech, John Goodden, Tore Stokland, Beate Timmermann, Pablo Hernáiz Driever, Martin U. Schuhmann, Ulrich W. Thomale, Amedeo A. Azizi, Monika Warmuth-Metz, Olaf Witt, Torsten Pietsch, Cornelis M. van Tilburg, Brigitte Bison, Shivaram Avula, Enrico Opocher, Daniela Kandels, RD Kortmann
Publikováno v:
Klinische Padiatrie. 231(3)
Low grade gliomas (LGGs) constitute the largest, yet clinically and (molecular-) histologically heterogeneous group of pediatric brain tumors of WHO grades I and II occurring throughout all pediatric age groups and at all central nervous system (CNS)
Publikováno v:
Pediatric hematology and oncology. 35(5-6)
BACKGROUND Two 14-year old boys with acute lymphocytic leukemia were treated according to the NOPHO-ALL-08 protocol with intrathecal methotrexate (MTX) on the same day. Due to a preparation error in the hospital pharmacy, they were both given 240 mg
Autor:
Rolf D. Kortmann, Amedeo A. Azizi, Olaf Witt, Torsten Pietsch, Brigitte Bison, Thomas Czech, Beate Timmermann, Cornelis M. van Tilburg, Astrid Gnekow, Tore Stokland, A. Y.N.Schouten Van Meeteren, John Goodden, Shivaram Avula, Enrico Opocher, Martin U. Schuhmann, Ulrich W. Thomale, Monika Warmuth-Metz, Daniela Kandels, Pablo Hernáiz Driever
Korrektur zu 10.1055/a-0889-8256
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3eb373e10955d286b48ac0fc0e19069f
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85079786052
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85079786052
Autor:
Hrvoje Miletic, Terje Nordberg, Snezana Maric, Tom Børge Johannesen, Jana Rydland, Tor Åge Myklebust, Bernt J. Due-Tønnessen, Kristin Smistad Myrmel, Ole Solheim, Anne Grete Bechensteen, Finn Wesenberg, Tore Stokland, Johan Cappelen, Ingrid Torsvik, Paulina Due-Tønnessen, Bård Krossnes, Viggo Moholdt, Tryggve Lundar, Gry Wikran, Bernward Zeller, Petter Brandal, Aleksandra Kepka, Kristin Solem, Einar Stensvold
Publikováno v:
66:e27910
Pediatric Blood & Cancer
Pediatric Blood & Cancer
Background: A previous study based on Norwegian Cancer Registry data suggested regional differences in overall survival (OS) after treatment for medulloblastoma (MB) and supratentorial primitive neuroectodermal tumor (CNS-PNET) in Norway. The purpose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f9f699f15b1e73cf5f46dd4d573f3b
http://hdl.handle.net/10852/76067
http://hdl.handle.net/10852/76067
Autor:
Astrid K. Gnekow, David A. Walker, Daniela Kandels, Susan Picton, null Giorgio Perilongo, Jacques Grill, Tore Stokland, Per Eric Sandstrom, Monika Warmuth-Metz, Torsten Pietsch, Felice Giangaspero, René Schmidt, Andreas Faldum, Denise Kilmartin, Angela De Paoli, Gian Luca De Salvo, Irene Slavc, Giorgio Perilongo, Sue Picton, David Walker, Per Erik Sandstrom, Niels Clausen, Mikko Arola, Olafur Gisli Jonsson, Ofelia Cruz, Aurora Navajas, Anna Teijeiro, Chantal Kalifa, Marie-Anne Raquin, Joris Verlooy, Volkmar Hans, Wolfram Scheurlen, Johannes Hainfellner, James Ironside, Keith Robson, Kari Skullerud, David Scheie, null NN, Marie-Madeleine Ruchoux, Anne Jouvet, Dominique Figarella-Branger, Arielle Lellouch-Toubiana, Daniela Prayer, Milena Calderone, Tim Jaspan, Soren Jacob Bakke, Eli Vazquez, Dominique Couanet, Rolf D. Kortmann, Karin Diekmann, Giovanni Scarzello, Roger Taylor, Knut Lote, Jordi Giralt, Christian Carrie, Jean Louis Habrand, Niels Soerensen, Thomas Czech, Paul Chumas, Bengt Gustavson, Michel Zerah, Bettina Wabbels, Maria Luisa Pinello, Alistair Fielder, Ian Simmons, Terje Christoffersen, Gabriele Calaminus, Knut Brockmann, Ronald Straeter, Friedrich Ebinger, Pablo Hernaiz-Driever, Herwig Lackner, Colin Kennedy, Adam Glaser, Bo Stromberg, Jose Ma Indiano, Chantal Rodary, Eric Bouffet, Didier Frappaz, Angela Emser, Suzanne Stephens, David Machin, Marie-Cécile Le Deley, Thore Egeland, Carolyn Freemann, Martin Schrappe, Richard Sposto
Publikováno v:
European Journal of Cancer
The use of chemotherapy to manage newly diagnosed low grade glioma (LGG) was first introduced in the 1980s. One randomised trial has studied two- versus four-drug regimens with a duration of 12 months of treatment after resection.Within the European
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ddc13a33f6fe385beac61c49f75440e
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144933
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-144933
Autor:
Astrid K. Gnekow, David A. Walker, Daniela Kandels, Susan Picton, null Giorgio Perilongo, Jacques Grill, Tore Stokland, Per Eric Sandstrom, Monika Warmuth-Metz, Torsten Pietsch, Felice Giangaspero, René Schmidt, Andreas Faldum, Denise Kilmartin, Angela De Paoli, Gian Luca De Salvo, Irene Slavc, Giorgio Perilongo, Sue Picton, David Walker, Per Erik Sandstrom, Niels Clausen, Mikko Arola, Olafur Gisli Jonsson, Ofelia Cruz, Aurora Navajas, Anna Teijeiro, Chantal Kalifa, Marie-Anne Raquin, Joris Verlooy, Volkmar Hans, Wolfram Scheurlen, Johannes Hainfellner, James Ironside, Keith Robson, Kari Skullerud, David Scheie, null NN, Marie-Madeleine Ruchoux, Anne Jouvet, Dominique Figarella-Branger, Arielle Lellouch-Toubiana, Daniela Prayer, Milena Calderone, Tim Jaspan, Soren Jacob Bakke, Eli Vazquez, Dominique Couanet, Rolf D. Kortmann, Karin Diekmann, Giovanni Scarzello, Roger Taylor, Knut Lote, Jordi Giralt, Christian Carrie, Jean Louis Habrand, Niels Soerensen, Thomas Czech, Paul Chumas, Bengt Gustavson, Michel Zerah, Bettina Wabbels, Maria Luisa Pinello, Alistair Fielder, Ian Simmons, Terje Christoffersen, Gabriele Calaminus, Knut Brockmann, Ronald Straeter, Friedrich Ebinger, Pablo Hernaiz-Driever, Herwig Lackner, Colin Kennedy, Adam Glaser, Bo Stromberg, Jose Ma Indiano, Chantal Rodary, Eric Bouffet, Didier Frappaz, Angela Emser, Suzanne Stephens, David Machin, Marie-Cécile Le Deley, Thore Egeland, Carolyn Freemann, Martin Schrappe, Richard Sposto
Publikováno v:
European Journal of Cancer
Background The use of chemotherapy to manage newly diagnosed low grade glioma (LGG) was first introduced in the 1980s. One randomised trial has studied two- versus four-drug regimens with a duration of 12 months of treatment after resection. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1b198b87ba76997a3fa8589fa2dcc7
http://hdl.handle.net/11573/1301732
http://hdl.handle.net/11573/1301732
Autor:
Päivi M. Lähteenmäki, S. de Fine Licht, Joachim Schüz, Per Kogner, Kjeld Schmiegelow, Tore Stokland, Naja Hulvej Rod, Catarina Träger, Lisbeth Samsø Schmidt
Publikováno v:
International Journal of Cancer. 131:E555-E561
Little is known about the etiology of hepatoblastoma. Because of the young age at diagnosis, several studies have looked at various birth characteristics. The purpose of our study was to investigate the incidence of hepatoblastoma in the Nordic count
Autor:
Tore Stokland, Magnus Sabel, Benedicte Bang, Henrik Hasle, Steen Rosthøj, Miriam Entesarian, Edvard Nordenskjöld, Samuel C. C. Chiang, Magnus Nordenskjöld, Toivo T. Salmi, Caroline Björklund, Britt-Marie Holmqvist, Ljubica Rajić, Hans-Gustaf Ljunggren, Marie Meeths, Janez Jazbec, Jacek Winiarski, Yenan T. Bryceson, Susan Pfeifer, Bengt Fadeel, Stephanie M. Wood, Heinrich Schlums, Gordana Jakovljević, Jan-Inge Henter
Publikováno v:
Meeths, M, Chiang, S C C, Wood, S M, Entesarian, M, Schlums, H, Bang, B, Nordenskjöld, E, Björklund, C, Jakovljevic, G, Jazbec, J, Hasle, H, Holmqvist, B-M, Rajic, L, Pfeifer, S, Rosthøj, S, Sabel, M, Salmi, T T, Stokland, T, Winiarski, J, Ljunggren, H-G, Fadeel, B, Nordenskjöld, M, Henter, J-I & Bryceson, Y T 2011, ' Familial hemophagocytic lymphohistiocytosis type 3 (FHL3) caused by deep intronic mutation and inversion in UNC13D ', Blood, vol. 118, no. 22, pp. 5783-93 . https://doi.org/10.1182/blood-2011-07-369090
Familial hemophagocytic lymphohistiocytosis (FHL) is an autosomal recessive, often-fatal hyperinflammatory disorder. Mutations in PRF1, UNC13D, STX11, and STXBP2 are causative of FHL2, 3, 4, and 5, respectively. In a majority of suspected FHL patient